Amplification and Enrichment Platforms for Liquid Biopsy-based Early Prognostication of Cancer, Canada

Registration Status: Completed

Objective: We will use blood samples from prostate cancer patients in a Canadian Cancer Society Innovation Grant project to amplify and enrich biomarkers for prognostication purposes. We aim to use blood samples collected through the APCaRI biobank: https://apcari.ca/our-research/biorepository/

Registered Biobank Name Amplification and Enrichment Platforms for Liquid Biopsy-based Early Prognostication of Cancer
Biobank Leader ROGER ZEMP
Country Canada
Email for biobank inquiries rzemp@ualberta.ca
Principal Investigator Roger Zemp
User Type
  • Mono: A biobank that supports a specific research project, may have few staff members, a small-scale accrual scope with little to no initial intention of releasing or distributing biospecimens to secondary parties
  • Oligo: A biobank that supports several research groups or clinical trials, may or may not be designed to release biospecimens outside their collaborative group
  • Poly: A biobank that has generally a larger accrual scope, resources, and multiple users outside the biobank proper
Biospecimen Collected: